SEC EDGAR · Insider purchase
INM: ADAR1 Capital Management, LLC; Schneeberger Daniel reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow INM- Became public
- Nov 9, 2026, 8:18 PM EST
- Event / period date
- Nov 5, 2026
- Collected
- Nov 9, 2026, 8:27 PM EST
Why this is connected
This filing identifies InMed Pharmaceuticals Inc. as the issuer of the security. The company's SEC identifier connects it to INM.
Reported transactions
ADAR1 Capital Management, LLC (10% owner); Schneeberger Daniel (10% owner)
2,640 shares · Common Shares
Nov 5, 2026 · $13.0953 per share
Value calculated from the reported shares and prices: $34,571.59.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-11-05</periodOfReport>
<notSubjectToSection16>1</notSubjectToSection16>
<issuer>
<issuerCik>0001728328</issuerCik>
<issuerName>InMed Pharmaceuticals Inc.</issuerName>
<issuerTradingSymbol>MTRI</issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001940272</rptOwnerCik>
<rptOwnerName>ADAR1 Capital Management, LLC</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>3503 WILD CHERRY DRIVE</rptOwnerStreet1>
<rptOwnerStreet2>BUILDING 9</rptOwnerStreet2>
<rptOwnerCity>AUSTIN</rptOwnerCity>
<rptOwnerState>TX</rptOwnerState>
<rptOwnerZipCode>78738</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>0</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>1</isTenPercentOwner>
<isOther>0</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001861120</rptOwnerCik>
<rptOwnerName>Schneeberger Daniel</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>3503 WILD CHERRY DRIVE</rptOwnerStreet1>
<rptOwnerStreet2>BUILDING 9</rptOwnerStreet2>
<rptOwnerCity>AUSTIN</rptOwnerCity>
<rptOwnerState>TX</rptOwnerState>
<rptOwnerZipCode>78738</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>0</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>1</isTenPercentOwner>
<isOther>0</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>0</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Shares</value>
</securityTitle>
<transactionDate>
<value>2026-11-05</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness>
<value></value>
</transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>2640</value>
</transactionShares>
<transactionPricePerShare>
<value>13.0953</value>
<footnoteId id="F1"/>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>98297</value>
<footnoteId id="F2"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>See Footnote</value>
<footnoteId id="F3"/>
<footnoteId id="F4"/>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<footnotes>
<footnote id="F1">The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.9500 to $13.3000, inclusive. Each Reporting Person undertakes to provide to Mentari Therapeutics, Inc., any security holder of Mentari Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.</footnote>
<footnote id="F2">On November 4, 2026, the Issuer effected a 1-for-10 reverse stock split of its outstanding common stock. The transaction reported herein occurred on November 5, 2026, after giving effect to the reverse stock split. On November 6, 2026, the Issuer completed its previously announced merger transaction and changed its name from InMed Pharmaceuticals Inc. to Mentari Therapeutics, Inc. and its trading symbol from INM to MTRI. Following completion of the merger and related transactions, the Reporting Persons ceased to beneficially own more than 10% of the Issuer's outstanding common stock and are no longer subject to Section 16.</footnote>
<footnote id="F3">The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.</footnote>
<footnote id="F4">For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.</footnote>
</footnotes>
<ownerSignature>
<signatureName>ADAR1 Capital Management, LLC By: Daniel Schneeberger, Manager /s/ Daniel Schneeberger</signatureName>
<signatureDate>2026-11-09</signatureDate>
</ownerSignature>
<ownerSignature>
<signatureName>/s/ Daniel Schneeberger</signatureName>
<signatureDate>2026-11-09</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.